相似文献
1
The epithelial-mesenchymal transition generates cells with properties of stem cells.
Cell. 2008 May 16;133(4):704-15. doi: 10.1016/j.cell.2008.03.027.
2
PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Oncotarget. 2016 Sep 27;7(39):64109-64123. doi: 10.18632/oncotarget.11627.
3
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Stem Cell Reports. 2013 Dec 27;2(1):78-91. doi: 10.1016/j.stemcr.2013.11.009. eCollection 2014 Jan 14.
4
Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells.
PLoS One. 2011;6(6):e20701. doi: 10.1371/journal.pone.0020701. Epub 2011 Jun 8.
5
Epithelial-mesenchymal transition and the stem cell phenotype.
Cell Stem Cell. 2008 Jun 5;2(6):511-2. doi: 10.1016/j.stem.2008.05.007.
6
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.
Breast Cancer Res. 2011 Feb 8;13(1):202. doi: 10.1186/bcr2789.
7
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors.
Oncogene. 2014 Jan 30;33(5):643-52. doi: 10.1038/onc.2012.614. Epub 2013 Jan 14.
8
MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.
Cell Death Dis. 2013 Feb 28;4(2):e514. doi: 10.1038/cddis.2013.37.
9
EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
PLoS Genet. 2012;8(5):e1002723. doi: 10.1371/journal.pgen.1002723. Epub 2012 May 24.
10
Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells.
Cell Signal. 2017 Aug;36:230-239. doi: 10.1016/j.cellsig.2017.05.009. Epub 2017 May 10.
引用本文的文献
1
The Role of Mitochondrial DNA in Modulating Chemoresistance in Esophageal Cancer: Mechanistic Insights and Therapeutic Potential.
Biomolecules. 2025 Aug 5;15(8):1128. doi: 10.3390/biom15081128.
2
Interpretation of the Transcriptome-Based Signature of Tumor-Initiating Cells, the Core of Cancer Development, and the Construction of a Machine Learning-Based Classifier.
Cells. 2025 Aug 14;14(16):1255. doi: 10.3390/cells14161255.
3
EMT-ciliary signaling in quasi-mesenchymal-stem-like cells drives therapeutic resistance and is a druggable vulnerability in triple-negative breast cancer.
EMBO Mol Med. 2025 Aug 26. doi: 10.1038/s44321-025-00289-1.
4
Role of autophagy‑modulating long non‑coding RNAs in tumor radioresistance (Review).
Oncol Rep. 2025 Nov;54(5). doi: 10.3892/or.2025.8975. Epub 2025 Aug 24.
5
Notch3 mediated TGF‑β1 activation enhances epithelial‑mesenchymal transition and cancer stemness in non‑small lung cancer.
Int J Oncol. 2025 Oct;67(4). doi: 10.3892/ijo.2025.5791. Epub 2025 Aug 24.
6
Exploration Biomarkers for Recurrence of Hepatocellular Carcinoma After Liver Transplantation Based on Bioinformatics Analysis.
Biochem Genet. 2025 Aug 18. doi: 10.1007/s10528-025-11227-8.
7
Epigenetic control in thyroid cancer: mechanisms and clinical perspective.
Cell Death Discov. 2025 Aug 17;11(1):387. doi: 10.1038/s41420-025-02688-2.
8
Anti-CD26 Antibody Suppresses Epithelial-Mesenchymal Transition in Colorectal Cancer Stem Cells.
Int J Mol Sci. 2025 Aug 6;26(15):7620. doi: 10.3390/ijms26157620.
9
Differential Effects of Snail-KO in Human Breast Epithelial Cells and Human Breast Epithelial × Human Breast Cancer Hybrids.
Int J Mol Sci. 2025 Jul 22;26(15):7033. doi: 10.3390/ijms26157033.
10
Nestin in multiple myeloma: emerging insights into a potential therapeutic target.
Front Oncol. 2025 Jul 29;15:1596928. doi: 10.3389/fonc.2025.1596928. eCollection 2025.
本文引用的文献
1
Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity.
Cancer Res. 2007 Sep 1;67(17):8131-8. doi: 10.1158/0008-5472.CAN-06-4493.
2
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers.
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10069-74. doi: 10.1073/pnas.0703900104. Epub 2007 May 30.
3
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Nat Rev Cancer. 2007 Jun;7(6):415-28. doi: 10.1038/nrc2131. Epub 2007 May 17.
4
Molecular definition of breast tumor heterogeneity.
Cancer Cell. 2007 Mar;11(3):259-73. doi: 10.1016/j.ccr.2007.01.013.
5
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.
Cancer Res. 2007 Mar 1;67(5):1979-87. doi: 10.1158/0008-5472.CAN-06-1479.
6
Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia.
Development. 2007 Mar;134(6):1231-42. doi: 10.1242/dev.02797. Epub 2007 Feb 7.
7
The Spemann organizer gene, Goosecoid, promotes tumor metastasis.
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):18969-74. doi: 10.1073/pnas.0608636103. Epub 2006 Dec 1.
8
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.
Nature. 2007 Jan 4;445(7123):106-10. doi: 10.1038/nature05372. Epub 2006 Nov 19.
9
Identification and expansion of human colon-cancer-initiating cells.
Nature. 2007 Jan 4;445(7123):111-5. doi: 10.1038/nature05384. Epub 2006 Nov 19.
10
Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.
Cancer Res. 2006 Oct 1;66(19):9339-44. doi: 10.1158/0008-5472.CAN-06-3126. Epub 2006 Sep 21.
Zotero 插件